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O R I G I N A L A R T I C L E
Metabolic and hormonal effects of ‘catch-up’ sleep in men with
chronic, repetitive, lifestyle-driven sleep restriction
Roo Killick*,†, Camilla M. Hoyos*,†, Kerri L. Melehan*,†, George C. Dungan II*, Jonathon Poh* and
Peter Y. Liu *,†,‡
*NHMRC Centre for Integrated Research and Understanding of Sleep, Woolcock Institute of Medical Research, University of
Sydney, †Faculty of Medicine, University of Sydney, Sydney, NSW, Australia and ‡Los Angeles Biomedical Research Institute at
Harbor-UCLA Medical Center and David Geffen School of Medicine, University of California Los Angeles, Torrance, CA, USA
Summary
Objective Acutely restricting sleep worsens insulin sensitivity in
healthy individuals whose usual sleep is normal in duration and
pattern. The effect of recovery or weekend ‘catch-up’ sleep on
insulin sensitivity and metabolically active hormones in individ-
uals with chronic sleep restriction who regularly ‘catch-up’ on
sleep at weekends is as yet unstudied.
Design 19 men (mean  SEM age 286  20 years, BMI
260  08 kg/m2) with at least 6 months’ history
(51  09 years) of lifestyle-driven, restricted sleep during the
working week (373  66 min/night) with regular weekend
‘catch-up’ sleep (weekend sleep extension 374  23%) com-
pleted an in-laboratory, randomized, crossover study comprising
two of three conditions, stratified by age. Conditions were
3 weekend nights of 10 hours, 6 hours or 10 hours time-in-bed
with slow wave sleep (SWS) suppression using targeted acoustic
stimuli.
Measurements Insulin sensitivity was measured in the morn-
ing following the 3rd intervention night by minimal modelling
of 19 samples collected during a 2-h oral glucose tolerance test.
Glucose, insulin, c-peptide, leptin, peptide YY (PYY), ghrelin,
cortisol, testosterone and luteinizing hormone (LH) were mea-
sured from daily fasting blood samples; HOMA-IR, HOMA-b
and QUICKI were calculated.
Results Insulin sensitivity was higher following three nights of
sleep extension compared to sustained sleep restriction. Fasting
insulin, c-peptide, HOMA-IR, HOMA-b, leptin and PYY
decreased with ‘catch-up’ sleep, QUICKI and testosterone
increased, while morning cortisol and LH did not change. Tar-
geted acoustic stimuli reduced SWS by 23%, but did not alter
insulin sensitivity.
Conclusions Three nights of ‘catch-up’ sleep improved insulin
sensitivity in men with chronic, repetitive sleep restriction.
Methods to improve metabolic health by optimizing sleep are
plausible.
(Received 3 December 2014; returned for revision 31 December
2014; finally revised 29 January 2015; accepted 6 February 2015)
Introduction
Chronic, lifestyle-driven sleep restriction is common in many
modern ‘24/7’ societies, with about 40% of individuals relying
on discretional time on weekends to ‘catch-up’ on sleep curtail-
ment during the working week.1,2 The prevalence of obesity and
type 2 diabetes mellitus is increasing to epidemic proportions,
particularly in developing nations, in line with increasing global-
ization, changes in nutrition and sedentary lifestyles.3 Epidemio-
logical, interventional and molecular experiments provide a
strong rationale linking sleep restriction with these metabolic
disorders. Recent large epidemiological studies have associated
sleep loss to the development of both obesity4 and diabetes mell-
itus,1 and short sleep duration to increased subcutaneous fat.5
Experimentally restricting or perturbing sleep for 1–14 nights in
duration worsens insulin sensitivity in healthy individuals whose
usual sleep is normal in duration and pattern.1 Molecular exper-
iments show that adipocytes from sleep-restricted individuals are
resistant to insulin’s effects on phosphorylated Akt, a mediator
in the insulin-signalling pathway.6 Together, these data indicate
that acute sleep restriction is metabolically harmful.
Although 40% of individuals ‘catch-up’ on sleep over the week-
end, the metabolic effects of catch-up sleep are relatively under-
studied with no interventional studies to date. Cross-sectional
epidemiological studies in children show that weekend ‘catch-up’
sleep is associated with a decreased risk of being overweight com-
pared to perpetual short sleepers.7–9 In adults, an hour of week-
end ‘catch-up’ sleep was associated with a 39% decreased risk of
hypertension.10 Given these epidemiological data, we therefore
examined whether three nights of a saturating amount of
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‘catch-up’ sleep following regular weekday sleep curtailment
would improve insulin sensitivity in those with a history of such
sleep patterns, compared to sustained sleep restriction. We also
tried to unravel mechanisms. An exploratory aim was to examine
the effect of targeted acoustic perturbation of slow-wave sleep
(SWS) on insulin sensitivity as SWS has been implicated mecha-
nistically in glucose homoeostasis.11 Finally, we also explored the
effect of both sleep restriction and experimental perturbation of
SWS on other hormones known to modify insulin sensitivity and
food intake.
Methods
Study protocol
The study complied with Good Clinical Practice guidelines,
applicable regulatory requirements and the Declaration of Hel-
sinki. All participants provided written informed consent to par-
ticipate in the study, which was approved by the Sydney South
West Area Health Service Human Research and Ethics Commit-
tee (Concord Zone). The study is registered with the Australia
New Zealand Clinical Trials Network, www.anzctr.org.au, num-
ber ACTRN12609000123246.
Screening and participants
Healthy male subjects aged between 18 and 50 years were
recruited through local advertising. Inclusion criteria included
regular sleep–wake patterns as per the description below and
being agreeable to spend two weekends at the research institute.
Exclusions included shift workers, habitual napping (more than
once per month from history), diabetes mellitus, a history of, or
symptoms suggesting, a co-existing sleep disorder, including
insomnia, obstructive sleep apnoea, parasomnias or restless legs
syndrome. Those with uncontrolled medical conditions or a his-
tory of psychiatric disorders or drug abuse, including use of any
sedative or neuroactive medications, or indeed any medication
that might affect sleep, were also excluded. Subjects could not
have crossed time zones within 1 month of the study visits.
Screening included a full medical history, physical examination
and detailed explanation of the study protocol. No subject had
type 2 diabetes mellitus from history, confirmed by oral glucose
tolerance test. Habitual sleep–wake patterns were objectively
assessed over 2 weeks with at-home actigraphy incorporating
sleep diary verification of sleep onset and wake-up times (Acti-
watchTM, Philips/Respironics, Murrysville, PA, USA), analysed by
two investigators. Subjects were included if mean weekday nightly
sleep period over 2 weeks, between Monday and Thursday nights
inclusive, was less than 65 h/night and mean nightly weekend
sleep period, Friday and Saturday nights, was greater than 25% of
the weekday mean. Sleep-disordered breathing was excluded by
three nights’ assessment with a portable single-channel nasal
flow recording device (Flow WizardTM, DiagnoseIT, Sydney,
Australia).12
Randomization
All participants underwent two out of two or three potential
study conditions, in a randomized order, two-period crossover
design. The three potential study conditions were 3 weekend
nights (Friday night to Monday morning) of (A) 10 h time in
bed (TIB) each night, (B) 6 h TIB each night or (C) 10 h TIB
with SWS suppression by acoustic stimuli (10 h↓SWS) each
night (Fig. 1). Those aged ≤35 years (group 1) could be ran-
domized to any two of the three conditions. Those >35 years
(group 2) could only be randomized to Condition A (6 h TIB)
or Condition B (10 h TIB). Men >35 years were not randomized
to Condition C (10 h↓SWS) because SWS is already reduced in
this age group. Two separate randomization lists for young and
older men were computer-generated in blocks of 4. There was a
minimum of 3 weeks of washout between each study visit.
Study visits
General. For 2 weeks prior to a study weekend visit, subjects
were asked to maintain their regular ‘catch-up’ sleep-wake
schedules at home and this was verified by inspection of
actigraphy and sleep diaries, with any deviation resulting in a
study weekend being rescheduled. Subjects were asked to restrict
caffeine and alcohol to two or less drinks or units per day at
home. The study was conducted within the chronobiology
laboratory in the research institute. Subjects were encouraged to
Fig. 1 Study design. Subjects were randomized to
undergo two of three (young men) or two (older
men) conditions in random order: that is, AB, BA,
AC, CA, BC or CB in young men; AB or BA in
older men. There were 3 weeks washout between
conditions.
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be sedentary and not to sleep outside of scheduled times, and
had their own bedroom with ensuite with access to a shared
living area. Ambient lighting was kept at less than 50 lux for the
duration of the study visit to minimize any phase shift. Subjects
were not permitted to exercise or leave the chronobiology
laboratory. Study staff ensured subjects did not nap, through
continuous camera or direct visual surveillance.
Sleep scheduling. Time of lights out was calculated by the
subject’s screening actigraphy. The weekday (Monday to
Thursday nights inclusive) mean sleep centre-point for each
subject was calculated, and lights-on and lights-off times were
individually centred on that time for each condition. Subjects
were only told of their lights-off time immediately prior to bed
on the first evening. They were instructed that if they woke
prior to lights on, they should remain in bed attempting further
sleep until the lights were switched on. Loudspeakers were
present in all bedrooms, irrespective of whether used or not.
Study schedule. Fig. 1 shows the study visit schedule. Subjects
arrived fasted on Friday morning for blood sampling (glucose,
insulin, c-peptide, leptin, peptide YY (PYY), total ghrelin,
cortisol, total testosterone and luteinizing hormone (LH)),
verification of their sleep compliance with actigraphy data and
to answer the Epworth Sleepiness Score (ESS)13 and Horne-
Ostberg Morningness-Eveningness Questionnaire (MEQ).14
Height and weight were measured by standard methods.
Subjects were asked to refrain from caffeine completely from
that time. They returned to the facility on Friday from 5 pm
and then did not leave the facility until after tests were
completed on Monday morning. Following each night of the
study condition, fasting blood samples were taken immediately
after wake up (for glucose, insulin, c-peptide, leptin, PYY, total
ghrelin, cortisol, testosterone and LH). On Monday morning
within 30–60 min of wake up, subjects underwent a frequently
sampled (19 samples), two-hour oral glucose tolerance test to
determine insulin sensitivity. After baseline fasting hormone
levels were taken through an intravenous cannula, 75 g of
glucose was administered orally, then samples were taken after
5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 70, 80, 90, 100, 110
and 120 min for insulin, c-peptide and glucose measurements.
Samples were centrifuged immediately and frozen to 80 °C
until assayed. Detailed hormonal assay methodology can be
found in Table S1. Insulin sensitivity was determined by
minimal model analysis.15,16 Area under the curve (AUC) for
glucose and insulin was calculated using the trapezoid rule.
HOMA-IR, HOMA-b17 and QUICKI18 indices of insulin
sensitivity were calculated.
Polysomnography and slow-wave sleep suppression. Polysomnography
was recorded each night using standard electrode placement
(Sandman Elite V.9.2, Tyco Healthcare, Denver, Colorado, USA).
Leads were referenced to the contralateral mastoid position. Sleep
stages were scored using standardized criteria19 by one scorer,
with strict attention to delta-wave voltage criteria. SWS was
suppressed using acoustic stimuli on all 3 weekend nights of
Condition C. Delta waves were recognized visually in real-time on
the central leads of the electroencephalogram (EEG) by the
researchers. When two or more consecutive delta waves were seen,
a mixed frequency ramped tone was played through bilateral
loudspeakers next to the subject’s bed, ramping from 40 to 95 dB
(measured at the approximate location of the subject’s head),
until delta activity was suppressed. If the maximum volume tone
did not control delta activity, the researchers would go into the
bedroom, gently disturb the subject and say their name.
Power spectral analysis. Power spectral analysis was performed
on a central lead of the EEG to determine non-rapid eye
movement (NREM) mean delta power, NREM relative delta
power density (% delta power/total power across all frequency
bands) and total NREM delta power (mean delta power x
number of 30 s epochs 92) after removal of EEG artefact using
an automated method with visual verification.20 If noise artefact
was present in over 25% of the channel, it was discarded from
analysis (10/114 studies). Lead C3-M2 was utilized unless the
signal quality was suboptimal, whereby C4-M1 was substituted
for all six nights for that subject (n = 4). Fast Fourier
transformation was performed on 5 s epochs over the entire
frequency bands, with the delta range (075–45 Hz) the primary
focus for analysis.20
Food intake and exercise. Meals were chosen from a menu,
which included healthy balanced frozen meals for breakfast,
lunch and dinner, with snacks available. Quantity of food was
not restricted over the 1st weekend visit. During the 2nd
weekend study visit, each subject was served exactly the same
meals and snacks they had consumed during the first weekend,
to ensure dietary intake was standardized over both weekends.
Food intake for each individual was summed from the available
nutritional information. No caffeine, alcohol or chocolate was
available. Breakfast was served 30 min after the subject’s wake-
up time, lunch at 1230 pm and dinner at 630 pm. All subjects
obliged with the dietary instructions and minimal deviation
occurred, except occasionally for food availability, when a
similar meal was provided. Diet was not monitored in between
study visits.
Statistical analysis
Our primary aim was to determine whether ‘catch-up’ sleep
would improve insulin sensitivity, and our exploratory aim was to
unravel potential mechanisms by which this might occur, such as
through changes in SWS and/or hormones known to be metaboli-
cally active. The primary outcome was the difference in insulin
sensitivity, determined by minimal modelling, after three nights of
each sleep condition. Secondary outcomes were disposition index
and hormones (leptin, PYY, ghrelin, cortisol, testosterone, LH).
Tertiary outcomes were insulin sensitivity measured by HOMA
and QUICKI, fasting and/or AUC glucose, insulin and c-peptide.
The polysomnographic findings are not outcomes – these vari-
ables were analysed to verify that the intervention (i.e. ‘catch-up’
sleep, SWS suppression, Cary) altered sleep duration and
© 2015 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
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architecture as expected. Data were analysed using SAS version
9.2 (SAS Institute, Cary, North Carolina, USA) using paired t-tests
and mixed model analysis for repeated measures where appropri-
ate incorporating ‘condition’, ‘day’ and interaction terms, with
two-tailed P values <005 considered significant. Normality of
data or of residuals was assessed, as appropriate. Data transforma-
tion was not required. Period and crossover effects were excluded
from available baseline data of each weekend.21 Results were
assessed separately for group 1 compared to overall, and a
‘group*condition’ term was utilized to assess for any age interac-
tion of the older group on the overall results. Data are described
as means and standard errors, or differences and 95% confidence
intervals as appropriate.
Results
Demographics
315 people responded to advertising; 49 attended full screening,
of which 21 men were randomized: 18 in group 1 (≤35 years)
and three in group 2 (>35 years), with 19 subjects completing
both weekend visits. The main reasons for screen failures were
not exhibiting sufficient sleep restriction during the working
week (n = 9 of 28; 32%), or not reaching the criteria set of 25%
‘catch-up’ sleep on weekends (n = 6 of 28; 22%). In group 1,
one subject was randomized who did not undergo either week-
end visit and another subject withdrew following 1 weekend due
to needle phobia. Due to within-person study design, neither
individual could be analysed. The following participants com-
pleted each of the three possible condition pairings:
10 h TIB/6 h TIB: n = 8
10 h TIB/10 h↓SWS: n = 6
6 h TIB/10 h↓SWS TIB: n = 5.
Screening characteristics are shown in Table 1, demonstrating
subjects were sleep restricted during the working work (6 h
12 min/night  7 min). All men showed a significant increase
in weekend sleep compared to weekday sleep (mean weekend
sleep extension 373%  24) (Fig. S1). Hence, a 6-h sleep
opportunity was almost identical to the average time spent
asleep during weekdays, whereas a 10-h sleep opportunity
exceeded the time each slept during weekends (Fig. S1). All sub-
jects had habituated to these sleep patterns regularly at home for
at least 6 months and on average 51 years  09. The most
common reason for these sleep patterns was working long hours,
alongside studying and time commuting to and from work and/
or study. MEQ excluded preference for morning or evening
(mean 473  15; ‘neither type’ category range 42–5814). Other
than age and BMI being higher, descriptively the older group
did not alter the overall mean demographics. ESS was within the
normal range, excluding subjective sleepiness. No significant dif-
ferences in BMI or sleep parameters by actigraphy for the
2 weeks leading up to study visits were found between the two
weekends (Table S2).
Sleep parameters – the intervention
PSG sleep parameters and power spectral analysis results are
shown in Figs 2 and Fig. S2. Across the pairs of conditions,
expected significant differences were seen in total sleep time
(TST) (Fig. 2a), sleep efficiency (percentage time asleep during
time in bed) (Fig. 2b) and sleep latency (Fig. 2a). Notably, sleep
efficiency exceeded 90% for all conditions, and the 10 h↓SWS
condition compared to 10 h did not significantly reduce TST
nor sleep efficiency, despite the acoustic stimuli (Fig. 2a,b). The
6h condition had a significantly reduced arousal index compared
to 10 h (P < 0001) or 10 h↓SWS (P < 0001), consistent with
maintaining a more consolidated sleep with sustained sleep
restriction (Fig. 2c). Arousal index in the 10 h↓SWS condition
compared to 10 h, although higher, did not reach significance
(P = 009). The 10 h↓SWS condition reduced SWS quantity by
23% (126 min, (234, 18); P = 002) compared to 10 h
and by 62% compared to 6 h (436 min, (550, 3236);
P < 0001), as expected by the experimental protocol (Fig. S2b).
The 6h condition had the highest SWS proportion (%TST)
across all pairs of conditions (compared to 10 h, P < 0001;
compared to 10 h↓SWS, P < 0001) (Fig. 2d).
In examining the delta power of the EEG, 10 h↓SWS reduced
mean NREM delta power by 10% (417 lV2, (693, 139);
P = 0005) and relative delta power compared to 10 h
(P = 00002), as anticipated by the acoustic stimuli protocol
(Fig. S2e,f). The 6-h condition had significantly higher mean
NREM delta power and relative delta power compared to either
10 h (P < 0001) or 10 h↓SWS (P < 0001), as expected with
sustained sleep restriction (Fig. S2e,f).
Metabolic outcomes- insulin sensitivity
Results for the main metabolic parameters are shown in Figs 3
and 4. Period and carryover effects were excluded by analysing
Table 1. Screening characteristics (means  SEM)
n = 19 Mean  SEM Range
Age (years) 286  20 19–49
Midweek sleep* 6 h 12 min  7 min 5 h 18 min–6 h 54 min
Weekend sleep† 8 h 30 min  9 min 6 h 59 min –9 h 39 min
Weekend sleep
extension‡ (%)
373  24 19–56
Duration of catch-up
sleep patterns (years)
51  09 05–15
MEQ score§ 471  15 34–58
*Defined as average rest period Monday to Thursday inclusive over
2 weeks of screening by actigraphy and diaries.
†Defined as average rest period Friday and Saturday over 2 weeks of
screening.
‡Defined as % more weekend sleep compared to midweek sleep over
2 weeks of screening.
§MEQ- Horne-Ostberg Morningness-Eveningness Questionnaire (definite
evening type 16–30; moderate evening type 31–41; neither type 42–58;
moderate morning type 59–69; definite morning type 70–86).
© 2015 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
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Friday baseline values where available. Insulin sensitivity (ISx)
was significantly increased following three nights of ‘catch-up’
sleep (10 h) compared to continuing sleep restriction (6 h)
(857 9 104/min/(lU/ml), (11, 161 9 104; P = 003)
(Fig. 3a). There were no significant differences between
10 h↓SWS and either 10 h (P = 017) or 6 h (P = 06). Changes
of similar magnitude and direction were seen for disposition
index (DI), but these were not statistically significant (Fig. 3b).
Glucose AUC was significantly lower in 10 h compared to 6 h
in the younger men 692 mmol min.L1 (1197, 186);
P = 002), but not in the young and old men together (P =
014) (Fig. 3c). Insulin AUC differences were not significant
(Fig. 3d). Daily fasting morning hormone levels showed signifi-
cant reductions in fasting insulin, c-peptide, HOMA-IR and
HOMA-b and an increase in QUICKI following 10 h compared
to 6 h (Fig. 4) – all consistent with improvements. Only 1% of
insulin, c-peptide and glucose values were missing. Certain
results showed an age effect, with the older subjects having
higher C-peptide, glucose and leptin levels; however, this did
not alter the overall significances of differences when an age fac-
tor was applied to the model.
Metabolic outcomes – appetite hormones, cortisol and
testosterone
Leptin was significantly reduced following 10h ‘catch-up’ sleep
compared to 6 h (169 ng/ml (06, 28); P = 0003), along
with a corresponding reduction in PYY (127 pg/ml (21,
233); P = 002), but no change was seen in total ghrelin
(P = 059) (Fig. 5a–c). There was no significant change in fast-
ing morning cortisol levels between any of the condition pair-
ings (Fig. 5d).
The amount of food consumed between weekend visits was
not significantly different for each individual (1st
weekend = 6230 kcal, 2nd weekend = 6291 kcal; P = n/s). Nor
was there any significant difference between the amount of
energy intake between sleep conditions, when specifically looking
at only the first weekend chronologically when food choices
were made, independent of condition pairing (10 h = 6394 kcal,
6 h = 5845 kcal, 10 h↓SWS = 6426 kcal; P = n/s). Only food
choices from the first weekend were analysed because subjects
were not allowed to rechoose on the second weekend. Further-
more, when exploring only those in the 10 h/6 h condition pair-
ing, no significant difference was seen between food choice as
determined by energy intake on the first weekend
(10 h = 6250 kcal, 6 h = 5844 kcal; P = n/s). Fasting morning
testosterone levels were significantly higher following 10 h com-
pared to 6 h (22 nM (02, 42); P = 003) in both the group as
a whole (n = 8) and in the younger group alone (n = 5)
(Fig. 5e). The older men (n = 3) had lower levels compared to
the younger men, as expected with ageing (P = 001). LH was
not significantly different between any of the condition pairings
(Fig. 5f).
Discussion
‘Catch-up’ sleep is highly prevalent with >40% of working aged
adults sleeping more on weekends compared to weekdays.2
Understanding the metabolic implications of these lifestyle
choices is therefore highly relevant. We show that men who reg-
ularly adopt lifestyle-driven, chronic, repetitive sleep restriction
with weekend ‘catch-up’ sleep significantly improved insulin
sensitivity by 45% following three nights of a saturating sleep
compared to ongoing sleep restriction, as measured by minimal
(a) (b)
(c) (d)
Fig. 2 Polysomnographic sleep parameters between
pairs of conditions averaged over three
experimental nights. (a) TST (mins), (b) sleep
efficiency (%TST), (c) arousal index (events/h), (d)
SWS proportion (%TST) 10 h/6 h n = 8, 10 h/
10 h↓SWS n = 6, 6 h/10 h↓SWS n = 5. Error bars
are SEM. * represents significance P < 005.
© 2015 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
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(a) (b)
(c) (d)
Fig. 3 Metabolic outcomes between pairs of
conditions from minimal model of an oral glucose
tolerance test performed on Monday after three
nights of each condition. (a) insulin sensitivity
(/min/(lU/ml)), (b) disposition index, (c) glucose
area under the curve (AUC- mmol/l. min), (d)
insulin AUC (iu/ml. min). 10 h/6 h n = 8, 10 h/
10 h↓SWS n = 6, 6 h/10 h↓SWS n = 5. Error bars
are SEM. * represents significance P < 005.
(a) (b)
(c) (d)
(e) (f)
Fig. 4 Metabolic outcomes between pairs of
conditions from daily fasting blood samples
showing mean values across Sat/Sun/Mon. (a)
glucose (mmol/l), (b) insulin (iu/ml), (c) c-peptide
(pmol/l), (d) HOMA-b, (e) HOMA-IR, (f)
QUICKI. 10 h/6 h n = 8, 10 h/10 h↓SWS n = 6,
6 h/10 h↓SWS n = 5. Error bars are SEM.
* represents significance P < 005.
© 2015 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
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model after an oral glucose challenge. HOMA-IR decreased and
QUICKI increased. Accordingly, three separate measures of ISx
all showed improvements with ‘catch-up’ sleep. These data are
novel and together attest to the veracity of this finding. Previous
studies have shown that sleep restriction of one night to 2 weeks
has a negative impact on markers of glucose homoeostasis,22–25
but have examined subjects with regular sleep patterns, unlike
those in our study. Our finding of a 45% improvement in ISx
with ‘catch-up’ sleep is complementary and consistent with pre-
vious studies showing a 20–25% worsening of ISx with sleep
restriction.1
‘Catch-up’ sleep decreased fasting insulin, c-peptide and
HOMA-b, likely reflecting the concomitant improvement in ISx.
‘Catch-up’ sleep increased morning testosterone and did not
change morning cortisol. These findings are consistent with
other studies of sleep restriction.26,27 Randomized controlled tri-
als directly show that testosterone treatment improves ISx in
men who are obese,28 as well as in men with disrupted and
reduced sleep from obstructive sleep apnoea.29 Testosterone
improves glycaemic control in men with type 2 diabetes mell-
itus30 and reduces obesity and metabolic syndrome.31 Meta-
analyses show significant reductions in fasting plasma glucose,
fat mass and triglycerides with testosterone therapy in men with
type 2 diabetes mellitus.30 Previous studies have shown that
sleep restriction can increase evening, but not morning, corti-
sol,22,24–26 with no change in mean cortisol across 24 h.1 Inter-
ventional studies conclusively show that increased afternoon/
evening cortisol worsens insulin resistance in humans32 and
rodents.33 These findings occur because maintaining cortisol
concentrations during the 4–6 h of the circadian nadir (early
evening) is important to avoid effects of glucocorticoid excess
on peripheral tissues.33 Whether or not sleep impacts insulin
sensitivity through these hormonal changes is plausible, but
remains to be determined.
We examined satiety and hunger hormones released by adi-
pose tissue (leptin-satiety signal), small intestine (PYY-satiety)
and stomach (ghrelin-hunger) as secondary outcomes. ‘Catch-
up’ sleep decreased leptin and PYY compared with continued
sleep restriction, but did not alter ghrelin or food choice deter-
mined by energy intake. Studies have shown conflicting changes
in appetite hormones with sleep restriction due to differing food
intake, energy balance at time of assessment, gender differences
and possible changes in circadian rhythm.1,26,34 However, our
subjects ate the same meals across both weekends, albeit
(a) (b)
(c) (d)
(e) (f)
Fig. 5 Metabolic outcomes between pairs of
conditions from daily fasting blood samples
showing mean values across Sat/Sun/Mon. (a)
leptin (ng/ml), (b) PYY (pg/ml), (c) ghrelin (pmol/
l), (d) cortisol (nmol/l), (e) testosterone (nM), (f)
lutenizing hormone (LH-iU/l). 10 h/6 h n = 8,
10 h/10 h↓SWS n = 6, 6 h/10 h↓SWS n = 5. Error
bars are SEM. * represents significance P < 005.
© 2015 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
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ad libitum during the first weekend. Energy expenditure was not
measured; however, exercise was not allowed. Circadian shift
was minimized, as sleep opportunity was centred individually to
home sleep patterns and lighting was <50 lux. Although
decreased leptin and PYY should decrease satiety, we did not
observe a change in energy intake. Although surprising, these
data are consistent with recent data showing sleep restriction
increased leptin and PYY, and decreased ghrelin in a carefully
conducted study utilizing 24-h assessment of these hormones34.
We found no change in ghrelin with ‘catch-up’ sleep, although
decreasing SWS increased ghrelin. This novel finding requires
replication in other studies, as we did not adjust for multiple
testing for this or any of the other secondary outcomes.
Slow-wave sleep is a metabolically active sleep stage, and oth-
ers have shown that disrupting SWS can worsen ISx.11 In our
hands, targeted acoustic stimuli significantly disrupted SWS and
reduced delta power, but the absolute effect, although signifi-
cant, was small in magnitude. ISx was not altered, in contrast
with previous studies.11,35 This discrepancy could be explained if
a minimal reduction in SWS required to worsen ISx was not
achieved in our chronically sleep-restricted subjects, or if other
factors such as sleep fragmentation and/or arousals per se are
ultimately responsible35. On the other hand, our study was likely
underpowered to show an effect of SWS suppression on ISx, in
part because both baseline SWS and ability to suppress SWS
were highly variable in our study population and also because it
proved to be much more difficult to suppress SWS in a popula-
tion that is chronically sleep deprived than we had originally
anticipated.
These experimental findings exploring chronic repetitive sleep
restriction are highly relevant because such sleep patterns are
common in modern society and it has been suggested that
chronic sleep restriction leads to the development of obesity
and diabetes mellitus,36 in addition to other cardiometabolic
consequences.37 Over a prolonged period of time (years or dec-
ades), this improvement in insulin sensitivity could be highly
relevant in delaying or even preventing prediabetes or type 2
diabetes mellitus in a relatively healthy young individual. In a
population of millions of individuals, this change in insulin
sensitivity would translate to decreased prediabetes and diabetes
mellitus in the community. Furthermore, interventional studies
now show that sleep restriction increases weight38 and
decreases fat proportion lost in those trying to lose weight
through planned negative energy balance.1 Studies attempting
to manipulate sleep in the home setting have not been ade-
quately powered to show changes in ISx given the increased
variability that can occur in an uncontrolled non-laboratory
environment. Nevertheless, larger community-based sleep exten-
sion trials are required, but need to be sufficiently large to
account for variable adherence to the sleep intervention, the
introduction of confounders outside of the laboratory and pos-
sibly for a between-group study design.
Indeed, this wide variability in ISx is one potential limitation
for our investigation. This variability was readily observed by
examining the interindividual differences in response to 10 h of
sleep repletion (Fig. 3a) and could be related to age, lifetime
duration of chronic sleep deprivation, degree of at-home sleep
restriction or many other variables. In fact, these factors may
contribute to the wide variability observed in ISx in the general
population. Our sample size was too small for us to determine
these factors, but the goal of the study was to determine effects
of recovery ‘catch-up’ sleep on ISx, and here, the crossover study
design allowed a paired statistical analysis to examine the effect
of sleep repletion within the same person, using 57 measure-
ments (19 measurements each for insulin, C-peptide and glu-
cose) to precisely measure ISx, thereby negating the impact of
interindividual differences in ISx among individuals. Indeed,
paired Student’s t-tests, as we implemented, remain valid with-
out an increase in type 1 error over 005 even with these sample
sizes39 and Student’s original paper utilized a sample size of 4.40
Another possible limitation is that 3, not 2, nights of ‘catch-up’
sleep was tested, whereas the latter might be more consistent
with a weekday/weekend pattern. However, our proof-of-concept
study of three nights ‘catch-up’ sleep is still feasible in the com-
munity, wherein additional sleep on the 3rd (Sunday) night
could be achieved with an earlier bedtime. Nevertheless, further
studies of one and two nights of sleep repletion are needed to
explore the chronology of metabolic recovery. Our population
was specifically in individuals with ‘catch-up’ sleep patterns and
may not be generalizable to other populations including those
with other sleep disorders, such as obstructive sleep apnoea.
Our study examines, for the first time, a population regularly
using ‘catch-up’ sleep. We show that ‘catch-up’ sleep improved
ISx over continued sleep restriction, thereby confirming that
extending sleep is potentially beneficial at least in nondiabetic
men with long-standing chronic, repetitive sleep restriction.
Critically, our intervention of 10-h sleep opportunity translated
to actual sleep as sleep efficiencies >90% and exceeded the usual
amount of sleep extension of every participant, raising the possi-
bility that their habitual attempts at ‘catch-up’ sleep were subop-
timal. These data suggest that many in our society should sleep
more, but further studies will be required to determine how
much more sleep is needed in which specific individuals and
whether planning to consistently sleep more every night is, in
the long-run, ultimately superior to the occasional 1, 2 or 3
nights of ‘catch-up’ sleep.
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